Clinical trial
A Randomized, Double Blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health
NCT05808049 is registered in ClinicalTrials.gov with Vedic Lifesciences Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health
- Lead sponsor
- Vedic Lifesciences Pvt. Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 6, 2022
- Completion date
- July 4, 2023
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.